LKB۱ dictates sensitivity to immunotherapy through Skp۲-mediated ubiquitination of immune checkpoint proteins in HCC with python analysis

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 119

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-6_011

تاریخ نمایه سازی: 14 مرداد 1405

چکیده مقاله:

Objective(s): Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with limited treatment options, particularly in advanced stages. Immune checkpoint inhibitors (ICIs) targeting PD-۱, PD-L۱, and CTLA-۴ have shown promise in cancer immunotherapy, but response rates in HCC remain variable. Materials and Methods: Hep۳B and HepG۲ HCC cells were cultured and genetically manipulated to overexpress or deplete LKB۱. Western blotting, real-time PCR, and immunofluorescence were used to assess PD-L۱ expression at the protein and mRNA levels. The role of Skp۲ in PD-L۱ regulation was evaluated through shRNA-mediated knockdown and overexpression. Additionally, kinase-dead LKB۱ mutants were expressed to determine the importance of LKB۱ kinase activity in PD-L۱ stability. ImageJ software and Python-based computational tools were employed for quantitative analysis of immunofluorescence and Western blot data.Results: LKB۱ overexpression up-regulated PD-L۱ protein levels in HCC cells, while its depletion reduced PD-L۱ expression, indicating a post-translational regulatory mechanism. Although Skp۲ expression remained unchanged upon LKB۱ modulation, Skp۲ overexpression in LKB۱-deficient cells increased PD-L۱ levels, suggesting a context-dependent role for Skp۲ in PD-L۱ stability. Furthermore, wild-type LKB۱, but not the kinase-dead mutant, restored PD-L۱ expression, highlighting the essential role of LKB۱ kinase activity in PD-L۱ regulation.Conclusion: This study identifies LKB۱ as a critical regulator of PD-L۱ stability in HCC, with implications for tumor immune evasion and immunotherapy response. While Skp۲ appears to influence PD-L۱ stability in specific contexts, LKB۱’s kinase activity is essential for PD-L۱ regulation.

کلیدواژه ها:

HCC ، Immune checkpoint - proteins ، LKB۱ ، Python analysis ، Skp۲

نویسندگان

Masoud khodarahmi

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Danial Amiri Manjili

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Foroozan Yarahmadi

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Tahere Mokhtari

Department of Pathology, Division of Experimental Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Adib Dashtizadeh

School of Pharmacy ,Tehran University of Medical Sciences,Tehran, Iran

Helia Rajabi Dezfooli

School of Pharmacy ,Tehran University of Medical Sciences,Tehran, Iran

Khaterehsadat Monirvaghefi

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Hossein Gharedaghi

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Sina Dolatshahi

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Zahra Hasanabadi

School of Pharmacy ,Tehran University of Medical Sciences,Tehran, Iran

Farzaneh Moammer

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Mahya Mobinikhaledi

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Aida Yavari Kondori

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Zahra Farajpour

School of Pharmacy ,Tehran University of Medical Sciences,Tehran, Iran

Pardis Kondori Varnosfaderani

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Zahra Hashemi

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Mohammad Amin Mahdizadeh

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Qumars Behfar

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

Siamak Sandoghchian Shotorbani

Immunology Research Center,Tabriz University of Medical Sciences,Tabriz,Iran

Nasibeh Sargazi Moghaddam

School of Medicine,Tehran University of Medical Sciences,Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, ...
  • Cassinotto C, Nogue E, Durand Q, Panaro F, Assenat E, ...
  • Balogh J, Victor Iii D, Asham EH, Burroughs SG, Boktour ...
  • Esfahani K, Roudaia L, Buhlaiga N, Del Rincon SV, Papneja ...
  • Marin-Acevedo JA, Soyano AE, Dholaria B, Knutson KL, Lou Y. ...
  • Mandlik DS, Mandlik SK, Choudhary HB. Immunotherapy for hepatocellular carcinoma: ...
  • Gan RY, Li HB. Recent progress on liver kinase B۱ ...
  • Nguyen K, Hebert K, McConnell E, Cullen N, Cheng T, ...
  • Lv L, Miao Q, Zhan S, Chen P, Liu W, ...
  • Li W, Zhu X, Fang J. Machine learning developed LKB۱-AMPK ...
  • Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: ...
  • Bradski G. The OpenCV Library. Dr Dobb’s Journal of Software ...
  • Data Structures for Statistical Computing in Python ۲۰۱۰ ...
  • Hunter JD. Matplotlib: A ۲D Graphics Environment. Comput Sci Eng ...
  • Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML. Post-translational modifiers of liver ...
  • Högner A, Moehler M. Immunotherapy in gastric cancer. Curr Oncol ...
  • Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, ...
  • Cui J-W, Li Y, Yang Y, Yang H-K, Dong J-M, ...
  • Alsaafeen BH, Ali BR, Elkord E. Resistance mechanisms to immune ...
  • Barroso-Sousa R, Forman J, Collier K, Weber ZT, Jammihal TR, ...
  • Fan Z, Wu C, Chen M, Jiang Y, Wu Y, ...
  • Wang N, Wang B, Maswikiti EP, Yu Y, Song K, ...
  • Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, ...
  • نمایش کامل مراجع